Can regulatory T cells improve outcomes of sensitised patients after HLA-Ab incompatible renal transplantation: study protocol for the Phase IIa GAMECHANgER-1 trial. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12882-023-03157-7
PubMed Identifier: 37118685
Publication URI: http://europepmc.org/abstract/MED/37118685
Type: Journal Article/Review
Volume: 24
Parent Publication: BMC nephrology
Issue: 1
ISSN: 1471-2369